Sophia Genetics
The company provides a cloud-based platform, SOPHiA DDM, which uses AI to analyze genomic, radiomic, and multimodal health data. It assists healthcare providers, including oncologists and geneticists, in generating actionable insights for diagnosing and treating cancer and rare disorders. The platform also supports biopharmaceutical companies by optimizing clinical trial development and market access strategies through data analytics.
Healthcare
Biotechnology
Software
Data Analytics
Oncology
Funding summary
- Total raised
- €211.7M
- Funding rounds
- 5
Investors in Sophia Genetics
Investors on record for Sophia Genetics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Sophia Genetics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors